«Pharmaceutical products / Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products»
HS code: 3002
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2015 | <hidden> |
2016 | <hidden> |
Total: | <hidden> |
Period | Weight, tons. |
---|---|
2015 | <hidden> |
2016 | <hidden> |
Total: | <hidden> |
Group product | 2015 | 2016 | Ch. | ∑ (2015-2016) | Ratio |
---|---|---|---|---|---|
06 300210: Immune serum, other blood fractions and immunological products | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300211: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300212: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300213: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300214: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300215: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300219: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300220: Vaccines for human medicine | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300230: Vaccines for veterinary medicine | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300290: Other | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
Total: | <hidden> | <hidden> | <hidden> |
№ | Country | ∑ (2015-2016) | Ratio |
---|---|---|---|
1 | Netherlands | <hidden> | <hidden>% |
2 | Austria | <hidden> | <hidden>% |
3 | Germany | <hidden> | <hidden>% |
4 | United Kingdom | <hidden> | <hidden>% |
5 | Denmark | <hidden> | <hidden>% |
6 | United States | <hidden> | <hidden>% |
7 | Poland | <hidden> | <hidden>% |
8 | Italy | <hidden> | <hidden>% |
9 | Cuba | <hidden> | <hidden>% |
10 | China | <hidden> | <hidden>% |
11 | Japan | <hidden> | <hidden>% |
12 | Spain | <hidden> | <hidden>% |
13 | Belarus | <hidden> | <hidden>% |
14 | Kazakhstan | <hidden> | <hidden>% |
15 | Czech Republic | <hidden> | <hidden>% |
16 | Armenia | <hidden> | <hidden>% |
17 | France | <hidden> | <hidden>% |
18 | Bulgaria | <hidden> | <hidden>% |
19 | Brazil | <hidden> | <hidden>% |
20 | Israel | <hidden> | <hidden>% |
... | ... | ... | ... |
The total for all countries: | <hidden> | 100% |
№ | Region | ∑ (2015-2016) | Ratio |
---|---|---|---|
1 | Moskva | <hidden> | <hidden>% |
2 | Bashkiriya | <hidden> | <hidden>% |
3 | Moskovskaya oblast | <hidden> | <hidden>% |
4 | Sverdlovskaya oblast | <hidden> | <hidden>% |
5 | Altayskiy kray | <hidden> | <hidden>% |
6 | Sankt-Peterburg | <hidden> | <hidden>% |
7 | Novosibirskaya oblast | <hidden> | <hidden>% |
8 | Kaliningradskaya oblast | <hidden> | <hidden>% |
9 | Vladimirskaya oblast | <hidden> | <hidden>% |
10 | Permskiy kray | <hidden> | <hidden>% |
11 | Tatarstan | <hidden> | <hidden>% |
By all regions: | <hidden> | 100% |